belimumab for lupus nephritis

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
belimumab for lupus nephritis	0.99	0.5	193	20	29
belimumab	1.29	0.6	4783	13	9
for	1.38	0.6	8422	32	3
lupus	0.56	0.4	5706	8	5
nephritis	0.78	0.9	2411	68	9

Keyword	CPC	PCC	Volume	Score
belimumab for lupus nephritis	1.28	0.6	3712	44
belimumab lupus nephritis approval	0.05	0.7	3629	27
belimumab lupus nephritis fda approval	1.49	0.2	5363	64
belimumab lupus nephritis nejm	0.65	0.1	1476	44
belimumab lupus nephritis phase 3	0.03	0.8	1561	71
belimumab lupus nephritis fda	0.2	0.6	8021	8
belimumab in lupus nephritis	0.92	0.5	6475	35
belimumab for systemic lupus erythematosus	1.93	0.4	4719	3
lupus nephritis approved drugs	0.78	0.9	6851	81
obinutuzumab for lupus nephritis	1.44	0.4	3332	85
benlysta lupus nephritis fda approval	1.48	0.3	676	19
rituximab lupus nephritis trial	0.57	0.6	8121	26
new treatments for lupus nephritis	0.96	0.5	8534	32
lupus nephritis clinical trials	1.69	0.4	9560	55
new drugs for lupus nephritis	1.06	0.1	8544	7
lupus nephritis new treatment	1.64	0.5	6473	52
belimumab fda approval history	1.6	0.1	9248	55
lupus fda approved medications	1.54	0.1	5293	83
is rituximab approved for lupus	1.32	0.9	2109	94
fda approved drugs for lupus	1.79	0.1	1796	97
rituximab for lupus nephritis	0.06	0.6	671	59
drugs approved for lupus	0.4	1	6973	18
alms trial lupus nephritis	0.3	0.9	3569	84
new medication trial for lupus	1.85	0.7	5537	65
lupus fda approves new drug	1.25	0.2	9843	54
belimumab primary membranous nephropathy	0.5	1	6798	19